ATE223492T1 - Mutanten des infektiösen rinder rhinotracheitis- virus und impfstoffe - Google Patents
Mutanten des infektiösen rinder rhinotracheitis- virus und impfstoffeInfo
- Publication number
- ATE223492T1 ATE223492T1 AT93913195T AT93913195T ATE223492T1 AT E223492 T1 ATE223492 T1 AT E223492T1 AT 93913195 T AT93913195 T AT 93913195T AT 93913195 T AT93913195 T AT 93913195T AT E223492 T1 ATE223492 T1 AT E223492T1
- Authority
- AT
- Austria
- Prior art keywords
- animals
- vaccines
- mutants
- glycoprotein
- mutated
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 241000701083 Bovine alphaherpesvirus 1 Species 0.000 title 1
- 241001465754 Metazoa Species 0.000 abstract 4
- 241000700605 Viruses Species 0.000 abstract 4
- 102000003886 Glycoproteins Human genes 0.000 abstract 2
- 108090000288 Glycoproteins Proteins 0.000 abstract 2
- 241000283690 Bos taurus Species 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 241000282849 Ruminantia Species 0.000 abstract 1
- 230000037430 deletion Effects 0.000 abstract 1
- 238000012217 deletion Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 101150030521 gI gene Proteins 0.000 abstract 1
- 230000037431 insertion Effects 0.000 abstract 1
- 238000003780 insertion Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16741—Use of virus, viral particle or viral elements as a vector
- C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/813—Viral vaccine for bovine species, e.g. cattle
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9207930A FR2693472B1 (fr) | 1992-06-26 | 1992-06-26 | Mutants du virus de la rhinotrachéite infectieuse bovine, délétés dans l'un des gènes des glycoprotéines mineures, vaccins préparés à partir de ces souches, méthodes de production et méthodes d'utilisation. |
| PCT/FR1993/000642 WO1994000586A2 (fr) | 1992-06-26 | 1993-06-25 | Mutants et vaccins du virus de la rhinotracheite infectieuse bovine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE223492T1 true ATE223492T1 (de) | 2002-09-15 |
Family
ID=9431272
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93913195T ATE223492T1 (de) | 1992-06-26 | 1993-06-25 | Mutanten des infektiösen rinder rhinotracheitis- virus und impfstoffe |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6224878B1 (de) |
| EP (1) | EP0605680B1 (de) |
| AT (1) | ATE223492T1 (de) |
| AU (1) | AU678763B2 (de) |
| CA (1) | CA2116355C (de) |
| DE (1) | DE69332264T2 (de) |
| FR (1) | FR2693472B1 (de) |
| NZ (1) | NZ253188A (de) |
| WO (1) | WO1994000586A2 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5783195A (en) * | 1991-07-18 | 1998-07-21 | Syntro Corporation | Recombinant infectious bovine rhinotracheitis virus S-IBR-052 and uses thereof |
| US6410033B1 (en) | 1987-07-27 | 2002-06-25 | Syntro Corporation | Recombinant infectious bovine rhinotracheitis virus |
| NZ276234A (en) * | 1993-11-05 | 1998-01-26 | Bayer Ag Substituted Under Sec | An attenuated replicating non pathogenic flavivirus (bovine viral diarrhoea virus - bvdv) vaccine |
| EP0663403A1 (de) * | 1993-11-23 | 1995-07-19 | Akzo Nobel N.V. | Impfstoffe von Boviner Herpesviren Typ I |
| CA2136381A1 (en) * | 1993-11-23 | 1995-05-24 | Gunther Keil | Vector vaccines of bovine herpesvirus 1 |
| ES2074965B1 (es) * | 1994-01-31 | 1996-05-01 | Hipra Lab Sa | Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen. |
| US6284251B1 (en) | 1996-02-26 | 2001-09-04 | Kansas State University Research Foundation | BHV-1 gene-deleted virus vaccine |
| EP1290146A1 (de) * | 2000-05-31 | 2003-03-12 | Akzo Nobel N.V. | Serotyp-chimäre ibdv stämme |
| US7906311B2 (en) | 2002-03-20 | 2011-03-15 | Merial Limited | Cotton rat lung cells for virus culture |
| AU2007352618B2 (en) | 2007-05-02 | 2013-07-18 | Boehringer Ingelheim Animal Health USA Inc. | DNA plasmids having improved expression and stability |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223424A (en) * | 1985-09-06 | 1993-06-29 | Prutech Research And Development | Attenuated herpesviruses and herpesviruses which include foreign DNA encoding an amino acid sequence |
| WO1987002058A1 (en) * | 1985-10-04 | 1987-04-09 | The Upjohn Company | Pseudorabies virus protein |
| EP0256092B1 (de) * | 1986-01-27 | 1998-04-08 | Syntro Corporation | Abgeschwächte herpesviren, herpesviren, die eine für aminosäuresequenzen kodierende fremd-dns enthalten, sowie impfstoffe, die diese enthalten |
| US5037742A (en) * | 1986-07-18 | 1991-08-06 | E. I. Du Pont De Nemours And Company | Pseudorabies virus recombinants and their use in the production of proteins |
| US4992051A (en) * | 1987-11-03 | 1991-02-12 | Novagene, Inc. | Infectious bovine rhinotracheitis virus mutants, methods for the production of same and methods for the use of same |
| AU2888089A (en) * | 1988-01-26 | 1989-07-27 | Baylor College Of Medicine | Infectious bovine rhinotracheitis virus insertion mutants, vaccines containing same, and methods for the production and use of same |
| US5585264A (en) * | 1988-07-15 | 1996-12-17 | University Of Saskatchewan | Nucleotide sequences encoding recombinant bovine herpesvirus type-1 GI, GIII and GIV polypeptides |
| ES2070997T3 (es) * | 1989-12-04 | 1995-06-16 | Akzo Nobel Nv | Virus de herpes recombinante de pavos y vacunas vector vivas derivadas de los mismos. |
| NL9100989A (nl) * | 1991-06-07 | 1993-01-04 | Stichting Centr Diergeneeskund | Bovine herpesvirus type 1 deletiemutanten, daarop gebaseerde vaccins, diagnostische kits voor detectie van bovine herpesvirus type 1. |
| WO1993002104A1 (en) * | 1991-07-18 | 1993-02-04 | Syntro Corporation | Recombinant infectious bovine rhinotracheitis virus |
| EP0663403A1 (de) * | 1993-11-23 | 1995-07-19 | Akzo Nobel N.V. | Impfstoffe von Boviner Herpesviren Typ I |
-
1992
- 1992-06-26 FR FR9207930A patent/FR2693472B1/fr not_active Expired - Lifetime
-
1993
- 1993-06-25 NZ NZ253188A patent/NZ253188A/en not_active IP Right Cessation
- 1993-06-25 EP EP93913195A patent/EP0605680B1/de not_active Expired - Lifetime
- 1993-06-25 AT AT93913195T patent/ATE223492T1/de not_active IP Right Cessation
- 1993-06-25 CA CA002116355A patent/CA2116355C/en not_active Expired - Lifetime
- 1993-06-25 AU AU43341/93A patent/AU678763B2/en not_active Expired
- 1993-06-25 DE DE69332264T patent/DE69332264T2/de not_active Expired - Lifetime
- 1993-06-25 WO PCT/FR1993/000642 patent/WO1994000586A2/fr not_active Ceased
-
1997
- 1997-09-04 US US08/924,345 patent/US6224878B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO1994000586A2 (fr) | 1994-01-06 |
| AU4334193A (en) | 1994-01-24 |
| CA2116355C (en) | 2004-08-24 |
| DE69332264D1 (de) | 2002-10-10 |
| FR2693472B1 (fr) | 1994-12-23 |
| DE69332264T2 (de) | 2003-04-17 |
| NZ253188A (en) | 1995-12-21 |
| US6224878B1 (en) | 2001-05-01 |
| AU678763B2 (en) | 1997-06-12 |
| EP0605680B1 (de) | 2002-09-04 |
| EP0605680A1 (de) | 1994-07-13 |
| CA2116355A1 (en) | 1994-01-06 |
| FR2693472A1 (fr) | 1994-01-14 |
| WO1994000586A3 (fr) | 1994-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE92531T1 (de) | Rekombinante herpes simplex-viren, vakzine und verfahren. | |
| DE69737886D1 (de) | Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays | |
| DE69125925D1 (de) | Rekombinante herpes simplex virus impfstoffe und methoden | |
| ATE350467T1 (de) | Rekombinantes herpesvirus aus trufhähnen und seine verwendungen | |
| HUT67138A (en) | Attenvated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof | |
| PH25776A (en) | Pseudorabies virus mutants incapable of producing glycoprotein x | |
| UA40571C2 (uk) | Мутант коров'ячого вірусу герпесу типу 1 (bhv-1), композиція вакцини для вакцинації тварин для захисту їх від bhv-1, композиція вакцини для вакцинації тварин для захисту їх від патогена | |
| RU93058614A (ru) | Мутант вируса герпеса, композиции, диагностические наборы, способы определения инфекции | |
| EP0232798A3 (de) | Pseudorabies-Virus-Mutanten, diese enthaltende Vakzine, Verfahren zu deren Herstellung sowie Methoden für deren Anwendung | |
| DE69332264D1 (de) | Mutanten des infektiösen rinder rhinotracheitis-virus und impfstoffe | |
| US4999296A (en) | Thymidine kinase negative insertion mutants of pseudorabies virus and methods for the production of same | |
| EP0294469A4 (de) | Impfstoffe und diagnosetest für haemophilus influenzae. | |
| US7060282B1 (en) | Attenuated equine herpesvirus | |
| AU2403188A (en) | Infectious bovine rhinotracheitis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same | |
| ATE175877T1 (de) | Avirulenter tollwut-impfstoff | |
| EP0432220A4 (en) | Vaccines and diagnostic assays for haemophilus influenzae | |
| DK0606452T3 (da) | Vektorvacciner fra rekombinant katteherpesvirus | |
| EP0668355A1 (de) | Impstoff zum Schutze von Pferden gegen Pferdeherpesvirus-Infektionen | |
| ES2074965A1 (es) | Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen. | |
| EP0949333A4 (de) | Mutierte antigene des masernvirus und die dafür kodierenden gene. | |
| JPH08168374A (ja) | 直接的細胞間伝染可能なｇＤ陰性ウシヘルペスウイルス突然変異体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |